Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


17.05.2021

1 AJR Am J Roentgenol
1 BJU Int
3 BMC Cancer
1 Br J Cancer
1 Cancer Res
1 Endocrinology
1 Eur Radiol
3 Eur Urol
1 Int J Radiat Oncol Biol Phys
5 Int J Urol
1 J Clin Oncol
6 J Magn Reson Imaging
2 J Nucl Med
1 J Urol
1 Oncogene
2 Oncology (Williston Park)
1 PLoS One
2 Prostate
2 Urol Int
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. WEI CG, Zhang YY, Pan P, Chen T, et al
    Diagnostic Accuracy and Interobserver Agreement of PI-RADS Version 2 and Version 2.1 for the Detection of Transition Zone Prostate Cancers.
    AJR Am J Roentgenol. 2021;216:1247-1256.
    PubMed         Abstract available


    BJU Int

  2. O'CALLAGHAN M, Papa N, Pase M, Frydenberg M, et al
    Patterns of care for prostate cancer treatment and improving outcomes - are national registries the answer?
    BJU Int. 2021 May 11. doi: 10.1111/bju.15366.
    PubMed        


    BMC Cancer

  3. HERNANDEZ VARGAS JA, Ramirez Barbosa PX, Gil Quijano AM, Valbuena AM, et al
    Patterns of breast, prostate and cervical cancer incidence and mortality in Colombia: an administrative registry data analysis.
    BMC Cancer. 2020;20:1097.
    PubMed         Abstract available

  4. THUREAU S, Marchesi V, Vieillard MH, Perrier L, et al
    Efficacy of extracranial stereotactic body radiation therapy (SBRT) added to standard treatment in patients with solid tumors (breast, prostate and non-small cell lung cancer) with up to 3 bone-only metastases: study protocol for a randomised phase II
    BMC Cancer. 2021;21:117.
    PubMed         Abstract available

  5. MA TM, Lamb JM, Casado M, Wang X, et al
    Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.
    BMC Cancer. 2021;21:538.
    PubMed         Abstract available


    Br J Cancer

  6. FILON M, Gawdzik J, Truong A, Allen G, et al
    Tandem histone methyltransferase upregulation defines a unique aggressive prostate cancer phenotype.
    Br J Cancer. 2021 May 11. pii: 10.1038/s41416-021-01398.
    PubMed         Abstract available


    Cancer Res

  7. MARTINEZ RS, Salji MJ, Rushworth L, Ntala C, et al
    SLFN5 regulates LAT1-mediated mTOR activation in castration-resistant prostate cancer.
    Cancer Res. 2021 May 13. pii: 0008-5472.CAN-20-3694.
    PubMed         Abstract available


    Endocrinology

  8. GANGULY S, Naik D, Muskara A, Mian OY, et al
    The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability.
    Endocrinology. 2021;162.
    PubMed         Abstract available


    Eur Radiol

  9. PENZKOFER T, Padhani AR, Turkbey B, Haider MA, et al
    ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging.
    Eur Radiol. 2021 May 15. pii: 10.1007/s00330-021-08021.
    PubMed         Abstract available


    Eur Urol

  10. CHENG HH
    Molecular Subtyping in the Neoadjuvant Setting in Prostate Cancer: Envisioning the Possibilities.
    Eur Urol. 2021 May 7. pii: S0302-2838(21)00308.
    PubMed        

  11. PHILIPSON RG, Romero T, Wong JK, Stish BJ, et al
    Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.
    Eur Urol. 2021 May 10. pii: S0302-2838(21)00314.
    PubMed         Abstract available

  12. VAN POPPEL H, Hogenhout R, Albers P, van den Bergh RCN, et al
    Reply to Laura Evangelista and Egesta Lopci's Letter to the Editor re: Hendrik Van Poppel, Renee Hogenhout, Peter Albers, et al. Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European C
    Eur Urol. 2021 May 5. pii: S0302-2838(21)00297.
    PubMed        


    Int J Radiat Oncol Biol Phys

  13. NITHIYANANTHAN K, Creighton N, Currow D, Martin JM, et al
    Population-Level Uptake of Moderately Hypofractionated Definitive Radiotherapy in the Treatment of Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2021 May 8. pii: S0360-3016(21)00460.
    PubMed         Abstract available


    Int J Urol

  14. HAGA N, Miyazaki T, Tsubouchi K, Okabe Y, et al
    Comprehensive approach for preserving cavernous nerves and erectile function after radical prostatectomy in the era of robotic surgery.
    Int J Urol. 2021;28:360-368.
    PubMed         Abstract available

  15. TATENUMA T, Makiyama K, Ito Y, Muraoka K, et al
    Correlation of urinary loss rate after catheter removal and long-term urinary continence after robot-assisted laparoscopic radical prostatectomy.
    Int J Urol. 2021;28:440-443.
    PubMed         Abstract available

  16. LOW AW, Chen K, Tan YG, Ng TK, et al
    Ambulatory robot-assisted laparoscopic radical prostatectomy with extended recovery by total extraperitoneal approach.
    Int J Urol. 2021;28:561-565.
    PubMed         Abstract available

  17. MATTI B, Zargar-Shoshtari K
    Age-adjusted reference values for prostate-specific antigen in a multi-ethnic population.
    Int J Urol. 2021;28:578-583.
    PubMed         Abstract available

  18. CLAPS F, Ramirez-Backhaus M, Mir Maresma MC, Gomez-Ferrer A, et al
    Indocyanine green guidance improves the efficiency of extended pelvic lymph node dissection during laparoscopic radical prostatectomy.
    Int J Urol. 2021;28:566-572.
    PubMed         Abstract available


    J Clin Oncol

  19. TEWARI AK, Gillessen S, Sweeney CJ
    Metastatic Prostate Cancer: In Search of More Granularity.
    J Clin Oncol. 2021 May 14:JCO2100643. doi: 10.1200/JCO.21.00643.
    PubMed        


    J Magn Reson Imaging

  20. SANFORD T, Harmon SA, Turkbey EB, Kesani D, et al
    Deep-Learning-Based Artificial Intelligence for PI-RADS Classification to Assist Multiparametric Prostate MRI Interpretation: A Development Study.
    J Magn Reson Imaging. 2020 Jun 1. doi: 10.1002/jmri.27204.
    PubMed         Abstract available

  21. HA HK
    Editorial for "Deep-Learning-Based Artificial Intelligence for PI-RADS Classification to Assist Multiparametric Prostate MRI Interpretation: A Development Study".
    J Magn Reson Imaging. 2020 Jun 16. doi: 10.1002/jmri.27254.
    PubMed        

  22. CONLIN CC, Feng CH, Rodriguez-Soto AE, Karunamuni RA, et al
    Improved Characterization of Diffusion in Normal and Cancerous Prostate Tissue Through Optimization of Multicompartmental Signal Models.
    J Magn Reson Imaging. 2021;53:628-639.
    PubMed         Abstract available

  23. HECTORS SJ, Chen C, Chen J, Wang J, et al
    Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
    J Magn Reson Imaging. 2021 May 10. doi: 10.1002/jmri.27692.
    PubMed         Abstract available

  24. BAI H, Xia W, Ji X, He D, et al
    Multiparametric Magnetic Resonance Imaging-Based Peritumoral Radiomics for Preoperative Prediction of the Presence of Extracapsular Extension With Prostate Cancer.
    J Magn Reson Imaging. 2021 May 10. doi: 10.1002/jmri.27678.
    PubMed         Abstract available

  25. HONG SB, Lee NK, Kim S, Son IW, et al
    Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
    J Magn Reson Imaging. 2020 Mar 27. doi: 10.1002/jmri.27141.
    PubMed         Abstract available


    J Nucl Med

  26. TREIBER H, Koenig A, Neesse A, Richter A, et al
    Liver enzyme elevation after (177)Lu-PSMA radioligand therapy for metastasized castration-resistant prostate cancer.
    J Nucl Med. 2021 May 14. pii: jnumed.120.258533. doi: 10.2967/jnumed.120.258533.
    PubMed         Abstract available

  27. BARBATO F, Fendler WP, Rauscher I, Herrmann K, et al
    PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of disease.
    J Nucl Med. 2021 May 14. pii: jnumed.121.262120. doi: 10.2967/jnumed.121.262120.
    PubMed         Abstract available


    J Urol

  28. SHAH N, Ioffe V
    Selecting Patients with Favorable Risk, Grade Group 2 Prostate Cancer for Active Surveillance-Does Magnetic Resonance Imaging Have a Role? Letter.
    J Urol. 2021 May 13:101097JU0000000000001880. doi: 10.1097/JU.0000000000001880.
    PubMed        


    Oncogene

  29. CRONIN R, Brooke GN, Prischi F
    The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance.
    Oncogene. 2021 May 10. pii: 10.1038/s41388-021-01810.
    PubMed         Abstract available


    Oncology (Williston Park)

  30. POLASCIK T
    Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright.
    Oncology (Williston Park). 2021;35:269.
    PubMed        

  31. HAYES M, Lin-Brande M, Isharwal S
    Primary Focal Therapy for Localized Prostate Cancer: A Review of the Literature.
    Oncology (Williston Park). 2021;35:261-268.
    PubMed         Abstract available


    PLoS One

  32. YADAV MP, Ballal S, Sahoo RK, Tripathi M, et al
    Long-term outcome of 177Lu-PSMA-617 radioligand therapy in heavily pre-treated metastatic castration-resistant prostate cancer patients.
    PLoS One. 2021;16:e0251375.
    PubMed         Abstract available


    Prostate

  33. ZHU Y, Wen J, Huang G, Mittlesteadt J, et al
    CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage.
    Prostate. 2021;81:81-88.
    PubMed         Abstract available

  34. SARTOR O, Appukkuttan S, Weiss J, Tsao CK, et al
    Clinical outcomes, management, and treatment patterns in patients with metastatic castration-resistant prostate cancer treated with radium-223 in community compared to academic settings.
    Prostate. 2021 May 12. doi: 10.1002/pros.24143.
    PubMed         Abstract available


    Urol Int

  35. PORCARO AB, Siracusano S, Amigoni N, Tafuri A, et al
    The Influence of Endogenous Testosterone on Incidental Prostate Cancer after Transurethral Prostate Resection.
    Urol Int. 2021 May 7:1-9. doi: 10.1159/000514391.
    PubMed         Abstract available

  36. KOPP D, Kopp J, Bernhardt E, Manka L, et al
    68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography-Based Primary Staging and Histological Correlation after Extended Pelvic Lymph Node Dissection in Intermediate-Risk Prostate Cancer.
    Urol Int. 2021 May 7:1-7. doi: 10.1159/000515651.
    PubMed         Abstract available


    Urology

  37. SCHUBBE ME, Gellhaus PT, Tobert CM, Mott SL, et al
    Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life.
    Urology. 2021 May 7. pii: S0090-4295(21)00368.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: